CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

STROSUTRO BIOPHARMA, INC.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $16.11 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$267.12M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-22 · Gerber Hans-Peter (CHIEF SCIENTIFIC OFFICER) · OTHER
  • 2026-06-02 · Chow Gregory K. (CFO) · OTHER
  • 2026-03-06 · Pauling David (Chief Admin. Ofcr. & GC) · OTHER
  • 2026-03-06 · Chung Jane (Chief Executive Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders111
Shares held25,168,920
Value$559.90M
Percent of shares outstanding151.79%
As of quarter end2026-06-30
RECENT NEWS
  • Sutro Biopharma names Lucas Donigian senior VP of business development
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
SUTRO BIOPHARMA, INC. (STRO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit